Swanton Robert Charles sold BCYC
October 2, 2025 · Form 4 insider transaction
Swanton Robert Charles sold 102 shares of Bicycle Therapeutics plc at $8.55 per share, a transaction worth $872.10. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
102
Price
$8.55
Total value
$872.10
InsiderSwanton Robert Charles
RoleDirector
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2025
Filing dateOctober 6, 2025
Shares owned after15,487
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on October 14, 2024.